WHO provides 2 conditional recommendations for casirivimab-imdevimab combination therapy in COVID-19.
Where this comes from
- Record sourced from PubMed, PMID 34871050.
- Also identified by DOI 10.7326/J21-0009.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rochwerg B, Agarwal A, Siemieniuk RA, et al. <b>Update to living WHO guideline on drugs for covid-19.</b> BMJ. 2021;374:n2219. 34556469.
Medical subject headings
- COVID-19